Fluo Labs Inc., a premarket clinical-stage medical device developer, announces its partnership with a leading global life sciences company, boosting the startups toward its goal of improving the quality of life for allergy sufferers worldwide.
New research that came out early this week is the latest study that suggests climate change is already making the lives of people worse, especially for those who are allergic to pollen.